Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02601820 · ClinicalTrials.gov registry record
The Patient-Reported Outcomes Project of HCV-TARGET
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 1,601
- Enrollment target
NCT02601820 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,601 participants.
The verdict
NCT02601820 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 1,601 participants
- Enrollment target
Study Summary
The PROP UP research study is funded by The Patient Centered Outcomes Research Institute (PCORI). PROP UP is a multi-centered prospective observational study that will evaluate all-oral treatment regimens for chronic hepatitis C viral (HCV) infection regarding several patient-reported outcomes (PROs) such as HCV-associated symptoms, treatment side effects, medication adherence, out of pocket costs, comorbid conditions, and long-term benefits of cure and harms of treatment to compare PROs of different treatment regimens, treatment durations, and patient subgroups. Participants will be recruited from 9 U.S. liver centers. Approximately 1920 patients with HCV infection who are prescribed a regimen containing Sofosbuvir/Ledipasvir(SOF/LED), SOF/Velpatasvir(SOF/VEL), Grazoprevir/Elbasvir(GRZ/ELB), OBV/PTV/r + DSV (PRoD), or daclatasvir/SOF (DAC/SOF) will be recruited and approximately 1600 patients who are approved and begin HCV treatment will be enrolled in the longitudinal study. PRO surveys will be evaluated before, during and after HCV treatment. PROP UP is a collaborative effort between behavioral and biomedical researchers, a patient engagement group and a patient advocacy organization.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,601 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02601820
The ClinicalTrials.gov registry entry for NCT02601820 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,601 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02601820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02601820 about?
NCT02601820 is a clinical study titled "The Patient-Reported Outcomes Project of HCV-TARGET". The PROP UP research study is funded by The Patient Centered Outcomes Research Institute (PCORI). PROP UP is a multi-centered prospective observational study that will evaluate all-oral treatment regimens for chronic hepatitis C viral (HCV) infection regarding several patient-reported outcomes (PROs...
What is the current status of trial NCT02601820?
This trial is currently completed. The enrollment target is 1,601 participants. The study started on 2015-11. Estimated completion is 2018-07.
Who is sponsoring clinical trial NCT02601820?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.